圣达生物(603079) - 2021 Q1 - 季度财报

Financial Performance - Net profit attributable to shareholders decreased by 62.53% to CNY 23,389,027.38 year-on-year[6] - Operating revenue declined by 2.34% to CNY 191,930,642.69 compared to the same period last year[6] - Basic earnings per share dropped by 63.16% to CNY 0.14[6] - Total revenue for Q1 2021 was CNY 121,169,804.28, a decrease of 18.2% compared to CNY 148,186,854.29 in Q1 2020[25] - Net profit for Q1 2021 was CNY 22,063,598.84, down 63.5% from CNY 60,562,048.65 in Q1 2020[24] - Total operating profit for Q1 2021 was CNY 24,694,798.97, a decrease of 66.5% from CNY 73,636,310.57 in Q1 2020[23] - The total profit for Q1 2021 was CNY 24,882,022.77, down 65.8% from CNY 72,760,841.78 in Q1 2020[23] Assets and Liabilities - Total assets increased by 7.31% to CNY 1,825,224,398.22 compared to the end of the previous year[6] - Total liabilities increased to CNY 348,181,410.76 in Q1 2021, up from CNY 217,432,800.76 in Q1 2020, reflecting a significant growth of 60.2%[20] - Owner's equity totaled CNY 1,269,768,963.92 as of March 31, 2021, compared to CNY 1,256,314,185.45 at the end of 2020, indicating a growth of 1.0%[20] - The total liabilities to equity ratio increased to 0.27 in Q1 2021 from 0.17 in Q1 2020, indicating a higher leverage[20] Cash Flow - Net cash flow from operating activities improved to CNY 20,351,680.33, compared to a negative cash flow of CNY -3,308,022.72 in the previous year[6] - The company reported cash received from sales and services of ¥189,584,244.37, an increase from ¥128,081,426.61 in the previous year, representing a growth of approximately 48%[28] - The company’s cash flow from operating activities totaled ¥205,978,539.97, up from ¥135,430,816.72 in the previous year, reflecting an increase of about 52%[28] - Cash flow from financing activities generated a net cash inflow of ¥80,405,801.71, compared to ¥45,104,274.99 in the previous year, marking an increase of approximately 78%[29] Investments and Expenses - Research and development expenses increased by 77.92% to 8,240,559.01 RMB from 4,631,489.97 RMB, indicating a significant investment in new projects[12] - The company plans to continue investing in R&D and expanding its market presence, as indicated by the increase in R&D expenses and sales growth[12] - Operating costs rose by 52.85% to 137,853,735.32 RMB, primarily due to increased sales volume and transportation costs included in the main business costs[12] - The company invested ¥150,000,000.00 in new projects, a substantial increase from ¥10,200,000.00 in the same quarter last year, reflecting a growth of over 1,370%[31] Shareholder Information - Total number of shareholders reached 18,167 at the end of the reporting period[9] - The largest shareholder, Zhejiang Shengda Group Co., Ltd., holds 26.51% of shares, with 6,300,000 shares pledged[9] Tax and Refunds - Cash received from tax refunds surged by 414.18% to 9,135,115.35 RMB, compared to 1,776,624.29 RMB in the previous year[12] - The company reported a 76.90% decrease in income tax expenses, amounting to 2,818,423.93 RMB, down from 12,198,793.13 RMB in the previous year[12]